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Signals in many biological processes can be ampli-
fied by recruiting multiple copies of regulatory pro-
teins to a site of action. Harnessing this principle,
we have developed a protein scaffold, a repeating
peptide array termed SunTag, which can recruit mul-
tiple copies of an antibody-fusion protein. We show
that the SunTag can recruit up to 24 copies of GFP,
thereby enabling long-term imaging of single protein
molecules in living cells. We also use the SunTag to
create a potent synthetic transcription factor by re-
cruitingmultiple copies of a transcriptional activation
domain to a nuclease-deficient CRISPR/Cas9 protein
and demonstrate strong activation of endogenous
gene expression and re-engineered cell behavior
with this system. Thus, the SunTag provides a versa-
tile platform for multimerizing proteins on a target
protein scaffold and is likely to have many applica-
tions in imaging and controlling biological outputs.INTRODUCTION
Recruitment of multiple copies of a protein to a target substrate
(e.g., DNA, RNA, or protein) presents a general principle for
signal amplification in biological systems. For example, binding
of multiple copies of a transcription factor to a single promoter
dramatically enhances transcriptional activation of the target
gene (Anderson and Freytag, 1991; Chen et al., 1992; Pettersson
and Schaffner, 1990). Similarly, the recruitment of multiple
copies of an RNA-binding protein to an mRNA can result in
potent regulation of translation (Pillai et al., 2004; Pique´ et al.,
2008). Protein localization and interactions also can be modu-
lated by the copy number of interaction siteswithin a polypeptide
sequence. For example, many nuclear proteins contain multiple
nuclear localization signal (NLS) sequences, which control
robustness of nuclear import (Luo et al., 2004).
The principle of signal amplification via protein multimerization
has also been widely used in imaging and engineering of biolog-ical systems. A commonly used method to study RNA localiza-
tion, even at the single-molecule level, is to insert multiple copies
(as many as 24) of the MS2-binding RNA hairpin into a target
RNA molecule, which then recruits many MS2-GFP fusion pro-
teins, fluorescently labeling the RNA molecule with many GFP
molecules (Bertrand et al., 1998; Fusco et al., 2003). The activity
of a RNA-binding protein can also be studied by artificially teth-
ering it to an RNA inmultiple copies using theMS2 system (Coller
and Wickens, 2007). Similar multimerization approaches have
also been used to fluorescently label a specific region of a
chromosome. For example, the LacO operon can be inserted
into a chromosomal locus in many tandem repeats and then
visualized by the recruitment of many copies of GFP-LacI
(Gordon et al., 1997). GFP-tagged DNA-binding proteins, such
as the CRISPR-associated protein Cas9, can also be used to
fluorescently label a native repetitive DNA sequence, as such
repetitive sequences recruit many copies of the GFP-tagged
DNA-binding proteins (Chen et al., 2013). Furthermore, as with
native transcriptional regulation, a gene can be artificially acti-
vated when a binding site for a synthetic transcription factor
is placed upstream of a gene in multiple copies; this principle
is employed in the ‘‘Tet-On’’ system for inducible transgene
expression (Huang et al., 1999; Sadowski et al., 1988). Taken
together, these studies demonstrate the power of introducing
multiple copies of protein-binding sites within RNA or DNA for
the purpose of signal amplification.
Despite the success of multimerizing nucleic-acid-based mo-
tifs within RNA and DNA, for protein recruitment, no comparable
and generic systemexists for controlling copy number of protein-
protein interactions. For fluorescence imaging, fusion of three
copies of GFP to a protein of interest has been used to increase
signal intensity, but a further increase in the copy number of fluo-
rescent proteins is challenging due to their size (25 kDa) and
bacterial recombination when constructing DNA plasmids en-
coding such proteins. Here, we describe a synthetic system for
recruiting as many as 24 copies of a protein to a target polypep-
tide chain. We demonstrate that this approach can be used to
create bright fluorescent signals for single-molecule protein im-
aging in living cells through the recruitment of 24 copies of GFP
to a target protein. We also demonstrate that the system can
be used to modulate gene expression through the recruitmentCell 159, 635–646, October 23, 2014 ª2014 Elsevier Inc. 635
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Figure 1. Identification of an Antibody-Peptide Pair that Binds Tightly In Vivo
(A) Schematic of the antibody-peptide labeling strategy.
(B) Schematic of the experiment described in (C) in which the mitochondrial targeting domain of mitoNEET (yellow box, mito) fused to mCherry and four tandem
copies of a peptide recruits a GFP-tagged intracellular antibody to mitochondria.
(C) ScFv-GCN4-GFP was coexpressed with either mito-mCherry-4xGCN4peptide (bottom) or mito-mCherry-FKBP as a control (top) in U2OS cells, and cells
were imaged using spinning-disk confocal microscopy. Scale bars, 10 mm.
See also Figure S1.of multiple copies of gene regulatory effector domains to a
nuclease-deficient CRISPR/Cas9 protein targeted to specific se-
quences in the genome. The ability to amplify biological signals
through controlled protein multimerization will likely have many
additional uses in biological research and biotechnology.
RESULTS
Development of the SunTag, a System for Recruiting
Multiple Protein Copies to a Polypeptide Scaffold
Proteinmultimerization on a single RNAor DNA template ismade
possible by identifying protein domains that bind with high affin-
ity to a relatively short nucleic acid motif. We therefore sought a
protein-based system with similar properties, specifically a pro-
tein that can bind tightly to a short peptide sequence (Figures 1A
and 1B). Antibodies are capable of binding to short, unstructured
peptide sequences with high affinity and specificity, and, impor-
tantly, peptide epitopes can be designed that differ from natu-
rally occurring sequences in the genome. Furthermore, whereas
antibodies generally do not fold properly in the cytoplasm, sin-
gle-chain variable fragment (scFv) antibodies, in which the
epitope-binding regions of the light and heavy chains of the anti-
body are fused to form a single polypeptide, have been success-
fully expressed in soluble form in cells (Colby et al., 2004; Lecerf
et al., 2001; Wo¨rn et al., 2000).636 Cell 159, 635–646, October 23, 2014 ª2014 Elsevier Inc.We expressed three previously developed single-chain anti-
bodies (Colby et al., 2004; Lecerf et al., 2001; Wo¨rn et al.,
2000) fused to EGFP in U2OS cells and coexpressed their
cognate peptides (multimerized in four tandem copies) fused
to the cytoplasmic side of the mitochondrial protein mitoNEET
(Colca et al., 2004) (referred to here as Mito, Figure S1A). We
then assayed whether the antibody-GFP fusion proteins would
be recruited to the mitochondria by fluorescence microscopy,
which would indicate binding between antibody and peptide
(Figure 1B). Of the three antibody-peptide pairs tested, only
the GCN4 antibody-peptide pair showed robust and specific
binding while not disrupting normal mitochondrial morphology
(Figures 1C and S1B). Thus, we focused our further efforts on
the GCN4 antibody-peptide pair.
The GCN4 antibody was optimized to allow intracellular
expression in yeast (Wo¨rn et al., 2000). In human cells, however,
we still observed some protein aggregates of scFv-GCN4-GFP
at high expression levels (Figure S2A). To improve scFv-GCN4
stability, we added a variety of N- and C-terminal fusion proteins
known to enhance protein solubility and found that fusion
of superfolder-GFP (sfGFP) alone (Pe´delacq et al., 2006) or
along with the small solubility tag GB1 (Gronenborn et al.,
1991) to the C terminus of the GCN4 antibody almost com-
pletely eliminated protein aggregation, even at high expression
levels (Figure S2A). Thus, we performed all further experiments
Mito-mCherry-4xGCN4pep
+ scFv-GCN4-sfGFP
sfGFP-linker-mCherry
sfGFP mCherrysfGFP mCherry
N
or
m
al
iz
ed
 ra
tio
 
G
FP
/m
C
he
rr
y 
flu
or
es
en
ce
Mito-mCherry-24xGCN4pep
+ scFv-GCN4-GFP
Mito-mCherry-24xGCN4pep
+ scFv-GCN4-sfGFP
t=-10s t=0s t=60s t=120s
t=-10s
BA
E
C D
M
ito
-m
C
he
rr
y-
24
xG
C
N
4p
ep
sc
Fv
-G
C
N
4-
G
FP
1210842
Time (min)
R
el
at
iv
e 
flu
or
es
ce
nc
e 1.0
0.8
0.6
0.4
0.2
0
n=20
16
12
8
4
0
16
12
8
4
0
60
20
40
0
N
or
m
al
iz
ed
 ra
tio
 
G
FP
/m
C
he
rr
y 
flu
or
es
en
ce
N
or
m
al
iz
ed
 ra
tio
 
G
FP
/m
C
he
rr
y 
flu
or
es
en
ce
mito-mCherry-
24xGCN4pep-5aa linker 
mito-mCherry-
4xGCN4pep-14aa linker 
mito-mCherry-
4xGCN4pep-5aa linker 
Figure 2. Characterization of the Off Rate and Stoichiometry of the Binding Interaction between the scFv-GCN4 Antibody and the GCN4
Peptide Array In Vivo
(A) Mito-mCherry-24xGCN4pep was cotransfected with scFv-GCN4-GFP in HEK293 cells, and their colocalization on mitochondria in a single cell is shown
(10 s). At 0 s, the mitochondria-localized GFP signal was photobleached in a single z plane using a 472 nm laser, and fluorescence recovery was followed by
time-lapse microscopy. Scale bar, 5 mm.
(B) The FRAP was quantified for 20 cells.
(C–E) Indicated constructs were transfected in HEK293 cells, and images were acquired 24 hr after transfection with identical image acquisition settings.
Representative images are shown in (C). Note that the GFP signal intensity in the mito-mCherry-24xGCN4pep + scFv-GCN4-GFP is highly saturated when the
same scaling is used as in the other panels. Bottom row shows a zoom of a region of interest: dynamic scaling was different for the GFP and mCherry signals, so
that both could be observed. Scale bars, 10 mm.
(D and E) Quantifications of the GFP:mCherry fluorescence intensity ratio on mitochondria after normalization. Each dot represents a single cell, and dashed lines
indicates the average value.
See also Figure S2.with scFv-GCN4-sfGFP-GB1 (hereafter referred to as scFv-
GCN4-GFP).
Very tight binding of the antibody-peptide pair in vivo is critical
for the formation ofmultimers on a protein scaffold backbone. To
determine the dissociation rate of the GCN4 antibody-peptide
interaction, we performed fluorescence recovery after photo-
bleaching (FRAP) experiments on scFv-GCN4-GFP bound to
the mitochondrial-localized mito-mCherry-4xGCN4pep. Afterphotobleaching, very slow GFP recovery was observed (half-
life of 5–10 min [Figures 2A and 2B]), indicating that the
antibody bound very tightly to the peptide. It is also important
to optimize the spacing of the scFv-GCN4 binding sites within
the protein scaffold so that they could be saturated by scFv-
GCN4 because steric hindrance of neighboring peptide binding
sites is a concern. We varied the spacing between neighboring
GCN4 peptides and quantified the antibody occupancy onCell 159, 635–646, October 23, 2014 ª2014 Elsevier Inc. 637
the peptide array using the mitochondrial localization assay
described above combined with quantitative fluorescence
microscopy (Figures 2C–2E and S2B). The ratio of GFP fluores-
cence (from the scFv-GCN4-GFP antibody) to mCherry fluores-
cence (present in one copy on the mito-4xGCN4pep scaffold)
on the mitochondria provided a measure of the number of
antibodies recruited to the protein scaffold. To correct for
different intensities of the two fluorescent proteins, this ratio
was normalized to the GFP-mCherry fluorescence intensity ratio
of a control protein in which GFP and mCherry were directly
fused (Figure S2B). We compared a short (GGSGG) and long
(GGSGGSGGSGGSGG) linker separating the 22 aa GCN4 pep-
tide and found an average GFP:mCherry corrected intensity ratio
of 3.4 ± 1.5 and 4.1 ± 1.6, respectively (n = 40 cells) (Figures 2C–
2E). Complete saturation of all binding sites would result in a
GFP:mCherry molar ratio of 4, whereas a maximal molar ratio
of 2 is expected if two antibodies could not bind to adjacent
peptides due to steric hindrance. Thus, the results from this
experiment indicate that a spacer as short as five amino acids
sufficiently separates peptides to allow binding of antibodies to
neighboring peptides. Importantly, in a peptide array containing
24 tandem copies of the peptide, separated by five aa linkers, we
found an averageGFP:mCherry corrected fluorescence intensity
ratio of 24 (Figures 2C and 2E). These results show that full anti-
body occupancy can be achieved with asmany as 24 copies of a
peptide binding site. Taken together, these results show that this
optimized GCN4 antibody-peptide pair meets all the require-
ments for an effective system for recruiting many copies of a
protein to a polypeptide scaffold in a controlled fashion. As the
GCN4 antibody-peptide pair allows ultrabright fluorescent label-
ing of molecules, we named the tagging system SUperNova
(SunTag) after the very bright stellar explosion.
Single-Molecule Imaging in Living Cells Using SunTag
Single-molecule imaging is a powerful emerging tool in cell
biology; in our first application of the SunTag, we tested whether
SunTag24x (24 copies of the peptide binding site) could be used
for single-molecule imaging in living cells (all imaging in this study
was performed at 37C). We first fused a plasma membrane
targeting domain (CAAX) to the C terminus of the SunTag24x
(SunTag24x-CAAX) (see Extended Experimental Procedures for
details on nomenclature). SunTag24x-CAAX was coexpressed
with the scFv-GCN4-GFP antibody fused to a nuclear localiza-
tion sequence (NLS) to sequester unbound antibody into the
nucleus (together referred to as SunTag24x-CAAX-GFP), which
resulted in the appearance of bright punctae on the plasma
membrane (Figure 3A). Individual fluorescent punctae could be
visualized diffusing in the plane of the membrane, either by spin-
ning disk confocal microscopy (Figure 3A and Movie S1) or by
total internal fluorescence microscopy (TIRF; data not shown).
The fluorescence intensity of single SunTag-CAAX foci was on
average 18-fold brighter than that of single sfGFP-CAAX mole-
culeswhen using identical imaging conditions (Figure 3A), largely
consistent with one antibody-GFP fusion bound to each peptide
in the 243 peptide array. This result also supports the conclusion
that individual fluorescence foci are indeed single SunTag24x-
CAAX molecules. As the SunTag foci were much brighter than
single GFP, it was possible to use lower excitation laser power638 Cell 159, 635–646, October 23, 2014 ª2014 Elsevier Inc.to detect single foci; when using 10 mW laser power when imag-
ing SunTag24x-CAAX compared with 55 mW for sfGFP-CAAX,
we observed that the signal-to-noise (single-molecule bright-
ness compared to neighboring background) was still 5.5-fold
greater, and the rate of photobleaching was more than 10-fold
lower for the SunTag compared to single GFP (half-life was 6.8
s; n = 150 molecules in 5 cells for SunTag24x-CAAX versus
0.57 s; n = 60 molecules in 4 cells for sfGFP-CAAX). Thus, due
to the brighter signal, SunTag24x-CAAX could be imaged at lower
laser intensities than sfGFP-CAAX, and single foci could be
imaged substantially longer.
Single-molecule imaging in the interior of the cell is more diffi-
cult than at the plasma membrane due to lower signal to back-
ground and the inability to use TIRF microscopy. We therefore
tested whether the SunTag could be used to image single mole-
cules deep inside the cell. When the SunTag24x was expressed
as a cytosolic protein (SunTag24x-GFP) or a nuclear protein by
fusing it to a nuclear import sequence (NLS-SunTag24x-GFP),
bright foci were observed rapidly diffusing in the cytoplasm or
nucleus, respectively, using spinning disk confocal microscopy
(Figure S3A and Movie S1). Thus, SunTag provides a very visible
fluorescent marker for single molecules within the cell interior.
Because the SunTagwith 24 boundGFPswould be1.4mDa,
much larger than a single GFP tag, we wished to determine
the effect on diffusion. Using single-molecule tracking (see the
Experimental Procedures section), we found that SunTag24x-
GFP-CAAX molecules diffused more slowly in the plasma mem-
brane than GFP-CAAX (diffusion coefficients of 1.3 ± 0.28 mm2/s;
n = 924 molecules in 3 cells versus 0.12 ± 0.02 mm2/s; n = 3,767
molecules in 4 cells [mean ± SEM], respectively) (Figures S3B
andS3C). Similarly, single-molecule tracking revealed a diffusion
coefficient of single cytoplasmic SunTag24x-GFP foci of 0.76 ±
0.06 mm2/s (mean ±SEM; n = 1,369 tracks in 6 cells) (Figure S3D).
This value is reduced compared to an average-sized protein
tagged with a single GFP (20 mm2/s) (Baum et al., 2014) but
well within the expected range of a multimer of 24 GFP mole-
cules (Baum et al., 2014). Together, these results show, as ex-
pected, that the relatively large SunTag reduces protein diffusion
compared to a single GFP.
We next imaged SunTag in other intracellular compartments.
The mitoNEET mitochondrial targeting domain fused to the
SunTag24x was expressed in U2OS cells together with scFv-
GCN4-GFP and imaged using spinning disk confocal micro-
scopy. Bright punctae could be observed very rapid diffusing in
the mitochondrial membrane (Movie S1). We also examined a
histone H2B-SunTag24x-GFP fusion and found that punctae ex-
hibited slow, highly confined diffusion in the nucleus (D = 2.1 ±
0.6 3 103 nm2/s) (Figures S3E and S3F and Movie S2), which is
consistent with an interaction with DNA. Together, these results
show that the SunTag24x can be targeted to different regions
of the cell and used as a single-molecule fluorescent reporter.
We next tested whether the SunTag could be used to make
single-molecule measurements of cytoskeletal motors moving
in vivo. Previous studies have imaged single motor proteins
fused to three copies of GFP using TIRF microscopy (Cai et al.,
2009), but the signal is relatively weak, and imaging by TIRF mi-
croscopy is limited to molecules that are very close to the glass
surface (<200 nm). We first fused SunTag24x to a truncated
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Figure 3. The SunTag Allows Long-Term Single-Molecule Fluorescence Imaging in the Cytoplasm
(A–H) U2OS cells were transfected with indicated SunTag24x constructs together with the scFv-GCN4-GFP-NLS and were imaged by spinning-disk confocal
microscopy 24 hr after transfection.
(A) A representative image of SunTag24x-CAAX-GFP is shown (left), as well as the fluorescence intensities quantification of the foci (right, blue bars). As a control,
U2OS were transfected with sfGFP-CAAX and fluorescence intensities of single sfGFP-CAAX molecules were also quantified (red bars). The average fluores-
cence intensity of the single sfGFP-CAAX was set to 1. Dotted line marks the outline of the cell (left). Scale bar, 10 mm.
(B) Cells expressing K560-SunTag24x-GFP were imaged by spinning disk confocal microscopy (image acquisition every 200 ms). Movement is revealed by a
maximum intensity projection of 50 time points (left) and a kymograph (right). Scale bar, 10 mm.
(C and D) Cells expressing both EB3-tdTomato and K560-SunTag24x-GFP were imaged, and moving particles were tracked manually. Red and blue tracks
(bottom) indicate movement toward the cell interior and periphery, respectively (C). The duration of the movie was 20 s. Scale bar, 5 mm. Dots in (D) represent
individual cells with between 5 and 20 moving particles scored per cell. The mean and SD are indicated.
(E and F) Cells expressing Kif18b-SunTag24x-GFP were imaged with a 250 ms time interval. Images in (E) show a maximum intensity projection (50 time- points,
left) and a kymograph (right). Speeds of moving molecules were quantified from ten different cells (F). Scale bar, 10 mm.
(G and H) Cells expressing both mCherry-a-tubulin and K560rig-SunTag24x-GFP were imaged with a 600ms time interval. The entire cell is shown in (G), whereas
H shows zoomed-in stills of a time series from the same cell. Open circles track two foci on the samemicrotubule, which is indicated by the dashed line. Asterisks
indicate stationary foci. Scale bars, 10 and 2 mm (G and H), respectively.
See also Figure S3 and Movies S1, S2, S3, S4, S5, and S6.
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version of kinesin-1 (termed K560), which is a processive motor
that lacks its cargo binding domain. Spinning-disk confocal im-
aging (10 frames/s) of K560-SunTag24x-GFP revealed bright
foci moving unidirectionally throughout the cell with an average
speed of 1.29 ± 0.24 mm/s (Figures 3B and S3G and Movie
S3). Due to the very low photobleaching, we were able to mea-
sure run lengths of single K560-SunTag24x-GFP molecules,
revealing an average run length of 1.28 ± 0.63 mm (Figure S3H),
which is consistent with previous measurements (0.91 mm) (Cai
et al., 2009). These results show that the SunTag allows long-
term single-molecule imaging of functional cytoskeletal motor
proteins in vivo.
Interestingly, when we imaged motility of K560-SunTag24x-
GFP (which moves exclusively toward plus ends of microtu-
bules), we found that a substantial fraction of K560-SunTag24x-
GFP motors moved toward the cell interior, indicating that the
microtubule tracks for these motors have their plus ends
directed inward (Figures 3C and 3D). This was surprising, as
microtubules are generally thought to be oriented with their
plus ends outward. Indeed, in these same cells, when microtu-
bule polarity was assessed using a conventional method of
visualizing EB3-tdTomato, a protein that selectively marks the
growing plus ends of microtubule (Akhmanova and Steinmetz,
2008), then microtubule plus ends were found to be oriented
almost exclusively toward the cell periphery (Figures 3C and
3D). By fusing the microtubule minus-end binding protein Cam-
sap2 to SunTag, we indeed could confirm that a subset of micro-
tubules had their minus ends near the cell periphery in these cells
(Figure S3I and Movie S4). Thus, live-cell imaging using K560-
SunTag24x-GFP as a reporter for microtubule polarity suggests
that cells contain a subpopulation of microtubules that are not
growing (and hence not interacting with EB3) and have inverted
polarity with respect to the cell periphery.
We next sought to test whether the SunTag could be used to
study cytoskeletal motors whose motility has not been charac-
terized. Kif18b is a member of the kinesin superfamily, which
has been shown to track with growing microtubule plus ends
and regulate their dynamics (Stout et al., 2011; Tanenbaum
et al., 2011). However, it is currently unclear whether individual
Kif18b molecules track the growing plus ends by rapidly binding
and releasing the plus end, as is the case for other plus-end
tracking proteins (Akhmanova and Steinmetz, 2008) or whether
it walks along the microtubule, remaining at the tip as it elon-
gates. Although Kif18b motility has not been directly measured,
homologs of Kif18b were found to move at rates in vitro that are
far too slow to keep up with microtubule growth (<100 nm/s),
arguing against the latter model. To analyze Kif18b’s motility
in vivo, we expressed full-length Kif18b with a C-terminal
SunTag24x in U2OS cells. Surprisingly, and unlike what was
reported for its homologs, single KIF18b-SunTag24x-GFP mole-
cules translocated along microtubules at high speeds (635 ±
163 nm/s; mean ± SD) (Figures 3E and 3F and Movie S5), which
is substantially faster than the speed of microtubule growth in
these cells (Tanenbaum et al., 2006). These results reveal that
the SunTag can be used to determine the physical properties
of molecular motors in vivo.
We also tested whether the SunTag could be used to image
single cytoskeletal filament dynamics in dense networks using640 Cell 159, 635–646, October 23, 2014 ª2014 Elsevier Inc.a novel type of fluorescence speckle microscopy (FSM).
Traditional FSM visualizes and tracks identifiable fluorescent
‘‘speckles’’ that arise from the stochastic variations in the incor-
poration of fluorescently labeled actin or tubulin monomers into
complex cytoskeletal networks (Waterman-Storer et al., 1998).
However, due to the stochastic number of fluorophores con-
tained within a diffraction-limited spot in traditional FSM, the
brightness of fluorescent speckles varies considerably. Further-
more because multiple fluorophores give rise to an individual
speckle, a speckle can contain fluorescently labeled monomers
that are present in different filaments, which is problematic for
following single filament dynamics. Therefore, we examined
whether single SunTag molecules could be used to create posi-
tional marks to follow the movements of individual microtubules
in living cells. For this purpose, we fused SunTag24x to an ATP
hydrolysis defective K560 mutant that forms a tight, rigor bond
with microtubules but does not translocate along them (termed
K560rig). When K560rig-SunTag24x-GFP was expressed in cells
at low levels, individual GFP foci colocalized with microtubules
(visualized by a-tubulin-mCherry), thus providing a sparse
labeling pattern of the microtubule network (Figures 3G and 3H
and Movie S6). Although the microtubule network appeared
largely static when the microtubules were imaged directly with
mCherry-tubulin (Movie S6), imaging of K560rig-SunTag24x-
GFP revealed many microtubules undergoing translocation
events in cells (Figure 3H and Movie S6). Microtubule translo-
cation occurred with an average speed of 1.1 ± 0.3 mm/s
(mean ± SD; n = 21 events in 4 cells), a rate suggesting that
they were propelled by microtubule-based motor proteins. The
frequency of microtubule translocation was 0.17 min1 per
cell, and these movements had a duration of 1.9 ± 0.7 s (mean
± SD, n = 21 events in 4 cells). Angular movements of the micro-
tubule axis also could be observed in cases in which a single
microtubule had two or more K560rig-SunTag24x-GFP mole-
cules bound as fiducial markers (Figure 3H andMovie S6). These
results reveal that the SunTag provides a powerful tool to study
movements of individual microtubule filaments in densemicrotu-
bule networks in living cells.
Optimizing the SunTag for Higher Protein Expression
The first generation construct of SunTag24x (termed v1)
described in the previous sections was expressed at extremely
low levels, which, although useful for single-molecule imaging,
may be suboptimal for other applications that require higher or
physiological concentrations of the protein. Based on the num-
ber of foci observed when the SunTag24x was coexpressed
with scFv-GCN4-GFP, we estimate that only a few hundred pro-
tein copies of v1 SunTag24x are expressed per cell. Consistent
with this, when GFP was directly fused to the v1 SunTag24x, a
very low overall GFP signal was observed by epifluorescence
compared to the expression of sfGFP alone on the same pro-
moter and plasmid (Figure 4A). The very low expression level
of the SunTag24x may be due to either a problem with the
mRNA (poor synthesis, stability, or translation) or an instability
of the peptide array after its translation. To distinguish between
these possibilities, we inserted a viral P2A ribosome skipping
sequence in between the 24xGCN4 peptide array and GFP,
which allows synthesis of two distinct proteins (i.e., 24xGCN4
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Figure 4. An Optimized Peptide Array for High Expression
(A) Indicated constructs were transfected in HEK293 cells and imaged 24 hr after transfection using wide-field microscopy. All images were acquired using
identical acquisition parameters. Representative images are shown (left), and fluorescence intensities were quantified (n = 3) (right).
(B) Sequence of the first and second generation GCN4 peptide (modified or added residues are colored blue, hydrophobic residues are red, and linker residues
are yellow).
(C–E) Indicated constructs were transfected in HEK293 cells and imaged 24 hr after transfection using wide-field (C) or spinning-disk confocal (D and E)
microscopy. (C) Representative images are shown (left), and fluorescence intensities were quantified (n = 3) (right). (D and E) GFP signal on mitochondria was
photobleached, and fluorescence recovery was determined over time. The graph (E) represents an average of six cells per condition. (E) shows an image of a
representative cell before photobleaching.
Scale bars in (A) and (C), 50 mm; scale bars in (D) and (E), 10 mm. Error bars in (A) and (C) represent SDs. See also Movie S7.peptide array and GFP) from the same mRNA. Insertion of the
P2A site in between 24xGCN4 peptide and GFP dramatically
increased GFP expression (Figure 4A), indicating that the
mRNA is present and efficiently translated, strongly suggesting
that poor protein stability explains the low expression of the
24xGCN4 peptide array.
The GCN4 peptide contains many hydrophobic residues (Fig-
ure 4B) and is largely unstructured in solution (Berger et al.,
1999); thus, the poor expression of the peptide array could be
due to its unstructured and hydrophobic nature. To test this
idea, we designed several modified peptide sequence that
were predicted to increase a-helical propensity and reduce hy-
drophobicity. One of these optimized peptides (v4, Figure 4B)
was expressed moderately well as a 243 peptide array, and
even higher expression was achieved with a 103 peptide array
(Figure 4C). Importantly, fluorescence imaging revealed that
the scFv-GCN4 antibody robustly bound to the GCN4 v4 peptide
array in vivo and FRAP analysis suggests that the scFv-GCN4
antibody dissociates with a similar slow off rate from the GCN4v4 peptide array as the original peptide (Figures 4D and 4E).
Furthermore, K560 motility could be observed when it was
tagged with the optimized v4 243 peptide array, indicating
that the optimized v4 peptide array did not interfere with protein
function (Movie S7). Together, these results identify a second
version of the peptide array that can be used for applications
requiring higher expression.
Activation of Gene Transcription Using Cas9-SunTag
Because the SunTag system could be used for amplification of a
fluorescence signal, we tested whether it also could be used to
amplify regulatory signals involved in gene expression. Tran-
scription of a gene is strongly enhanced by recruiting multiple
copies of transcriptional activators to endogenous or artificial
gene promoters (Anderson and Freytag, 1991; Chen et al.,
1992; Pettersson and Schaffner, 1990). Thus, we thought that
robust, artificial activation of gene transcription might also be
achieved by recruiting multiple copies of a synthetic transcrip-
tional activator to a gene using the SunTag. Recently, a highlyCell 159, 635–646, October 23, 2014 ª2014 Elsevier Inc. 641
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Figure 5. dCas9-SunTag Allows Genetic
Rewiring of Cells through Activation of
Endogenous Genes
(A) Schematic of gene activation by dCas9-VP64
and dCas9-SunTag-VP64. dCas9 binds to a gene
promoter through its sequence-specific sgRNA
(red line). Direct fusion of VP64 to dCas9 (top) re-
sults in a single VP64 domain at the promoter,
which poorly activates transcription of the down-
stream gene. In contrast, recruitment of many
VP64 domains using the SunTag potently activates
transcription of the gene (bottom).
(B–D) K562 cells stably expressing dCas9-VP64 or
dCas9-SunTag-VP64 were infected with lentiviral
particles encoding indicated sgRNAs, as well as
BFP and a puromycin resistance gene and
selected with 0.7 mg/ml puromycin for 3 days to kill
uninfected cells. (B and C) Cells were stained for
CXCR4 using a directly labeled a-CXCR4 antibody,
and fluorescence was analyzed by FACS. (D)
Trans-well migration assays (see Experimental
Procedures) were performed with indicated
sgRNAs. Results are displayed as the fold change
in directional migrating cells over control cell
migration.
(E) dCas9-VP64 or dCas9-SunTag-VP64 induced
transcription of CDKN1B with several sgRNAs.
mRNA levels were quantified by qPCR.
(F) Doubling time of control cells or cells expressing
indicated sgRNAs was determined (see Experi-
mental Procedures section). Graphs in (C), (D), and
(F) are averages of three independent experiments.
Graph in (E) is average of two biological replicates,
each with two or three technical replicates. All error
bars indicate SEM.
See also Figure S4.versatile, synthetic transcriptional activator was developed by
fusing the herpes virus transcriptional activation domain VP16
(or four copies of VP16, termed VP64) to a nuclease-deficient
mutant of the CRISPR effector protein Cas9 (dCas9), which
can be targeted to any sequence in the mammalian genome us-
ing sequence-specific small guide RNAs (sgRNAs) (Cheng et al.,
2013; Farzadfard et al., 2013; Gilbert et al., 2013; Hu et al., 2014;
Kearns et al., 2014; Maeder et al., 2013; Mali et al., 2013; Perez-
Pinera et al., 2013). Although targeting of dCas9-VP64 was able
to increase transcription of the targeted gene, the level of gene
activation using dCas9-VP64 was generally very low, most often
less than 2-fold (Cheng et al., 2013; Hu et al., 2014; Mali et al.,
2013; Perez-Pinera et al., 2013), thus severely limiting the
potential use of this system. However, consistent with multiple
transcriptional activators being required to stimulate robust
transcription, a GFP reporter containing multiple binding sites
for a single sgRNA was potently activated by dCas9-VP64
(Gilbert et al., 2013). In addition, recruitment of multiple copies
of dCas9-VP64 to a native promoter using multiple nonoverlap-642 Cell 159, 635–646, October 23, 2014 ª2014 Elsevier Inc.ping sgRNAs also greatly enhanced tran-
scriptional activation (Cheng et al., 2013;
Hu et al., 2014; Maeder et al., 2013; Mali
et al., 2013; Perez-Pinera et al., 2013).
We therefore wondered whether recruit-
ment of multiple VP64 domains to a single molecule of dCas9 us-
ing the SunTag would enhance the ability of dCas9 to activate
endogenous transcription (see Figure 5A).
To test whether dCas9 could be tagged with the SunTag, we
used an imaging-based approach in which dCas9-SunTag24x_v4
was coexpressed with scFv-GCN4-GFP (dCas9-SunTag24x_v4-
GFP) and targeted to telomeres using a telomere-specific
sgRNA. When examined by fluorescence microscopy, very
bright dots were observed in the nucleus, similar to previous
work with dCas9 directly labeled with GFP (dCas9-GFP) (Chen
et al., 2013) (Figure S4A). Analysis of dCas9-SunTag24x_v4-GFP
data showed that telomere labeling was 19.7 ± 6.2-fold
(mean ± SD) (n = 100 telomeres in 5 cells [dCas-GFP] or n =
120 telomeres in 6 cells [dCas9-SunTag24x_v4-GFP]) brighter
compared to those labeled by the dCas9 directly fused to
GFP, which is consistent with the recruitment of 24 copies of
GFP to a single dCas9 molecule (Figures S4A and S4B). As a
control, in the absence of the sgRNA targeting the telomere, nu-
clear GFP fluorescence was diffuse (Figure S4A). Analysis of
telomere mobility revealed a very similar diffusion coefficient for
telomeres labeled with dCas9-GFP and dCas9-SunTag24x_v4-
GFP (3.1 ± 0.6 3 103 nm2/s [n = 511 telomeres in 8 cells] versus
2.8 ± 0.8 3 103 nm2/s [255 telomeres in 5 cells], respectively)
(Figure S4C), indicating that SunTag labeling of telomeres did
not alter their mobility. Thus, dCas9-SunTag can efficiently re-
cruit multiple proteins to a single genomic locus and can be
used for very bright labeling of telomeres.
Next, scFv-GCN4-GFP was fused to VP64 to test whether
recruitment of multiple VP64 domains to a promoter would
enhance transcription of the downstream gene. K562 cell lines
were generated expressing either dCas9-VP64 (Gilbert et al.,
2013) alone or coexpressing dCas910x_v4 with GCN4-sfGFP-
NLS-VP64 (hereafter referred to as dCas9-SunTag-VP64).
dCas9-SunTag10x_v4 was used for these experiments, as we
found similar maximal activation and less cell-to-cell variation
in gene expression compared to the dCas9-SunTag24x_v4
(data not shown). As a target gene, we selected CXCR4, a trans-
membrane receptor known to stimulate cell migration, which
is normally poorly expressed in K562 cells. dCas9-VP64 and
dCas9-SunTag-VP64-expressing cells were infectedwith a lenti-
virus that encoded either a control sgRNA (sgNeg) or an sgRNA
targeting CXCR4 (sgCXCR4; three different sgRNA were tested).
The levels of CXCR4 protein were determined five days after
lentivirus infection. We found minimal activation of CXCR4
expression using dCas9-VP64 with the three sgRNAs tested
(Figure 5C). In contrast, strong activation (10- to 50-fold)
was observed with all three CXCR4 sgRNAs using dCas9-
SunTag10x_v4-VP64 (Figures 5B and 5C). These results show
that robust transcriptional activation can be achieved by
SunTag-dependent multimerization of transcriptional activation
domains at an endogenous gene promoter using a single sgRNA.
We next wished to test whether transcriptional regulation us-
ing dCas9-SunTag-VP64 could induce a biological response.
CXCR4 is a chemokine receptor that stimulates cell migration
in response to activation by SDF1a (Brenner et al., 2004). We
tested whether activation of CXCR4 in K562 could induce migra-
tion in response to SDF1a using a transwell migration assay. We
found that activating CXCR4 expression using dCas9-SunTag-
VP64 dramatically stimulated cell migration by an order of
magnitude (Figure 5D). In contrast, very weak (<2-fold) enhance-
ment of cell migration was observed using CXCR4 activation by
dCas9-VP64 (Figure 5D). This result indicates that dCas9-
SunTag-VP64-dependent gene activation is sufficiently potent
to affect the behavior of these cells. Surprisingly, cells express-
ing the highest level of CXCR4 showed less cell migration,
suggesting that there may be an optimum level of CXCR4
expression for stimulation of cell migration (compare Figure 5C
with Figure 5D).
CXCR4 is normally expressed at very low levels in K562 cells,
so we tested whether the expression of a well-expressed
gene could also be increased using SunTag-dependent tran-
scriptional activation. For this purpose, we chose the cell-cycle
inhibitor CDKN1B (also known as p27kip1). CDKN1B mRNA
expression level was determined in both dCas9-VP64 and
dCas9-SunTag-VP64 cells with four different sgRNAs. Very little
activation of CDKN1B transcription was observed using dCas9-
VP64 (28% increase in mRNA at best) (Figure 5E), whereas 3/4sgRNAs robustly activated CDKN1B in dCas9-SunTag-VP64
cells (330% for the best sgRNA) (Figure 5E). Furthermore, as ex-
pected for increased levels of the cell-cycle inhibitor CDKN1B,
activation of CDKN1B with dCas9-SunTag-VP64 significantly
reduced cell growth (Figure 5F). In contrast, activation of
CDKN1B with dCas9-VP64 had little impact on cell growth
(Figure 5F). Taken together, these results show that the
SunTag-dependent signal amplification robustly enhances tran-
scriptional activation by dCas9-VP64 and allows functional re-
engineering of cell behavior through precise control of gene
expression.
DISCUSSION
Amplification of biological signals is important for many biolog-
ical processes, as well as for imaging and bioengineering.
Here, we have developed a versatile protein-tagging system,
the SunTag, which can be used to increase fluorescence of
genetically encoded proteins, as well as amplify gene expres-
sion. The SunTag system provides a proof of concept of the
power of controlled protein multimerization and could form the
basis for developing other protein multimerization strategies.
Imaging Applications of the SunTag
The SunTag represents the brightest genetically encoded fluo-
rescent tagging system available and has several major advan-
tages over existing imaging methods. First, due to its extremely
high signal, a low expression level of SunTag-proteins is suffi-
cient for imaging and thus avoids potential problems associated
with protein overexpression. For example, we have found that
overexpression of GFP-mitoNEET is detrimental to mitochon-
drial function (data not shown). However, we have achieved
very bright images of mitochondria with much lower expression
of mitoNEET-SunTag24x-GFP than can be achieved by single
copy GFP tagging. Second, bright labeling of both organelles
and single molecules allows imaging with much lower light
illumination, which could minimize phototoxicity during long-
term imaging. Third, bright labeling using the SunTag will likely
be beneficial for automated tracking, especially single-molecule
tracking in vivo, as such algorithms work best with a high signal-
to-noise ratio. Fourth, the SunTag allows single-molecule imag-
ing deep inside the cytoplasm and nucleus, in contrast to TIRF
microscopy, which is mainly applicable to molecules close to
the cell membrane. Finally, SunTag, which can be used to pro-
duce bright, single-molecule labels on cytoskeletal filaments,
has advantages over traditional FSM, which relies on stochastic
fluctuations in the distribution of many fluorophores (Waterman-
Storer et al., 1998).
We also show that SunTag is a powerful single-molecule re-
porter of intracellular processes. For example, K560-SunTag
movements revealed a stable subset of microtubules with
reversed polarity in U2OS cells, which was not evident from
tracking growing microtubules with EB3-tdTomato. We demon-
strate that K560rig-SunTag can be used to observe microtubule
sliding in the cytoplasm; this method also could be powerful for
studying microtubule movements in the mitotic spindle or axon,
where very high microtubule densities preclude visualization of
single microtubules by traditional imaging with GFP-tubulin.Cell 159, 635–646, October 23, 2014 ª2014 Elsevier Inc. 643
dCas9-SunTag-GFP allows much brighter labeling of genomic
loci than dCas9 directly fused to GFP. Previous work revealed
that dCas9-GFP could also be used to image a nonrepetitive
DNA sequence if 36 nonoverlapping sgRNAs were used (Chen
et al., 2013). It will be interesting to test whether a nonrepetitive
DNA sequence can be imaged using dCas9-SunTag with a
smaller number of sgRNAs. Overall, these results show that
the SunTag is a versatile tool for single-molecule imaging and
very bright labeling of intracellular structures and organelles.
In this study, we have developed two different versions of the
SunTag, v1 and v4. Themajor advantage of the v1 scaffold is that
it is expressed at very low levels, simplifying single-molecule
imaging. However, using weak promoters to drive expression
of the v4 scaffold, we have found that is also possible to perform
single-molecule imaging. We also found that the v1 scaffold
shows some aggregation at higher protein concentrations,
whereas the v4 scaffold did not. Thus, for many imaging applica-
tions, the v4 scaffold expressed from weak promoters (see
Extended Experimental Procedures) may be superior.
Although imaging using the SunTag hasmany advantages, the
large size of the tag itself represents a potential drawback. The
SunTag has the potential to interfere with the activity or half-life
when fused to a protein. These caveats are true of single GFP
tagging as well but are more a concern with the SunTag due to
its much larger size (1,400 kDa, with 24 bound antibody-
GFPs). As is true of any tagging strategy, the suitability of SunTag
will need to be determined on a protein-by-protein basis and
taking into account the goals of a particular experiment. None-
theless, in this study, we provide examples of where the SunTag
does not interfere with protein activity (kinesin motility) or locali-
zation (MitoNeet, Camsap2, Histone H2B, dCas9). In this study,
we mostly used SunTag as a single-molecule reporter (e.g., an
in vivo motor activity assay, microtubule polarity and movement,
chromatin dynamics, and telomere localization andmotility), and
in many of those cases, we used truncated or inactivated pro-
teins rather than native proteins. For studies that require exam-
ining functions of particular proteins in their native state, it will
be important to test protein functionality, for example by genetic
complementation experiments.
Using SunTag to Control Gene Transcription and
Engineer Cell Behavior
The second application of the SunTag, for which we provide a
proof of concept, is the amplification of biological signaling
pathways. Transcriptional regulation is a powerful example, as
transcriptional output is strongly dependent on the number of
transcriptional activators recruited to the gene promoter (Ander-
son and Freytag, 1991; Chen et al., 1992; Pettersson and Schaff-
ner, 1990). Indeed, previous attempts to activate transcription
of endogenous genes using a single dCas9 fused to the tran-
scriptional activation domain VP64 generally resulted in weak
transcriptional activation. However, several studies showed
that robust gene activation was possible using multiple sgRNAs
targeting the same promoter or when multiple sgRNA binding
sites were present in an artificial promoter (Cheng et al., 2013;
Gilbert et al., 2013; Hu et al., 2014; Maeder et al., 2013; Mali
et al., 2013; Perez-Pinera et al., 2013). In contrast, our results
demonstrate that the dCas9-SunTag-VP64 transcriptional sys-644 Cell 159, 635–646, October 23, 2014 ª2014 Elsevier Inc.tem can robustly activate the expression of an endogenous
gene using a single sgRNA. This method not only simplifies sin-
gle gene activation but also opens possibilities for activating
multiple genes simultaneously, potentially allowing complex ge-
netic rewiring of cells or organisms. For example, generation of
induced pluripotent stem cells (iPS) requires expression of four
transcription factors (Takahashi and Yamanaka, 2006) and
induced human cardiomyocytes requires expression of five fac-
tors (Fu et al., 2013). It will be very interesting to test whether
such cell fate decisions can be directed by activation of endog-
enous genes using the SunTag, rather than through gene overex-
pression with transfected plasmids.
The ability to upregulate gene expression using dCas9-
SunTag with a single sgRNA also opens the door to large-scale
genetic screens to uncover phenotypes that result from
increased gene expression. This application will be especially
important for understanding the effects of gene upregulation in
cancer. In addition, large-scale activation screens could be
used to identify proteins that promote induced pluripotency
(Takahashi and Yamanaka, 2006) or, conversely, promote differ-
entiation to a specific cell lineage.
SunTag might also have applications in promoting transcrip-
tional silencing. Previous work has found that Cas9 fused to
transcriptional silencing domain fuse can inhibit gene-specific
transcription (Gilbert et al., 2013), but in most cases, some
residual transcription was observed. Recruitment of many
transcriptional silencing domains to a single promoter via
dCas9-SunTag could potentially enhance gene silencing for
loss-of-function studies. This approach could complement wild-
type Cas9 nuclease-mediated gene knockout and might be
especially useful for the analysis of essential genes and noncod-
ing RNAs. In addition, multiple types of transcriptional activators
or repressors could be recruited to a single scaffold, which may
be required for maximal transcriptional activation or repression.
Advantage of the SunTag over Direct Fusion of Protein
Multimers
Here, we tag single molecules with up to 24 copies of GFP or 10
copies of VP64 using the SunTag system. Indirect labeling of
proteins using the SunTag has several major advantages over
direct fusion of many copies of the fluorescent proteins or regu-
latory domains to the protein of interest. First, it is likely very diffi-
cult to generate plasmids containing 24 copies of a protein due
to the large size and bacterial plasmid recombination. Second,
the SunTag allows a high level of flexibility, as only a single ge-
netic element needs to be modified to generate an entirely new
protein multimer. Third, previous attempts to increase transcrip-
tional output by increasing the copy number of VP64 in a direct
protein fusion were not effective (Cheng et al., 2013), indicating
that the molecular configuration of the SunTag is more efficient
for transcriptional activation than a single chain fusion.
Future Developments of the SunTag System
The SunTag system is based on a scFv antibody and its epitope.
Antibody-based systems have several major advantages,
including their very high affinity and their ability to recognize
short peptides. However, a major drawback of antibodies is
that they are generally poorly expressed in the cytoplasm and
are relatively large in size. Several alternatives to antibodies have
been developed, including DARPins, which are small, highly
stable proteins that can be evolved in vitro to bind their epitope
with high affinity (Binz et al., 2004). Such proteins could form
the basis of future work on a second generation SunTag
system. Furthermore, development of a second, orthogonal sys-
tem could allow two-color single-molecule imaging, as well as
dual transcriptional regulation that could allow activation and
silencing of different genes in the same cell. Finally, another
important future tool will be creating an inducible recruitment
system, which could, for example, enable temporal gene regula-
tion. In summary, SunTag and its potential future derivatives that
operate using the same principles, represents a powerful system
that allows single-molecule imaging and transcriptional activa-
tion of endogenous genes and that could find much broader
uses in biological research and bioengineering.
EXPERIMENTAL PROCEDURES
Cell Culture and Plasmids
HEK293andU2OScellsweregrown inDMEM/10%FCS/Pen/Strep.K562cells
were grown in RPMI-1640, containing 25 mM HEPES, with 10% FCS/Pen/
Strep. HEK293 and U2OS cells were transfected with PEI (Sigma) and Fugene
6 (Roche), respectively. Sequences and discussion of constructs are provided
in the Extended Experimental Procedures and Table S1. For optimization of
plasmid expression levels, see Figure S5 (related to Experimental Procedures).
Imaging and Quantitation
Cells were grown in 96-well glass bottom dishes and were imaged on an
inverted Nikon TI spinning disk confocal microscope with the Nikon Perfect
Focus system, 1003 1.45 NA objective, an Andor EM-CCD camera, and
Micro-Manager software (Edelstein et al., 2010). Images in Figures 4A and
4C were acquired using wide-field illumination, a 203 air objective, and a
Hamamatsu CMOS Flash 4.0 camera.
To determine the number of antibodies bound to a single peptide array, a
sfGFP-linker-mCherry fusion protein was imaged using image acquisition
parameters for which GFP and mCherry fluorescence intensities were equal.
Using the same acquisition parameters, fluorescence intensity ratio of the
mito-mCherry-peptide array and GFP-tagged antibody was determined.
To measure fluorescence intensities of single foci, a circular region of inter-
est (ROI) with a diameter of 0.5 mm was applied, and an average background
(same ROI measured in five different areas of the cell that did not contain a
fluorescent foci) was subtracted. Kinesin run lengths and speeds were deter-
mined by kymographs analysis (Sirajuddin et al., 2014). Single-molecule
tracking was performed in 2D using Fiji Trackmate. MSD plots were generated
in Matlab using the X,Y tracking coordinates generated by Trackmate. Diffu-
sion coefficients were calculated based on MSD plots.
Quantification of Protein and mRNA Levels
To determine the levels of CXCR4 and CDKN1B transcriptional activation,
K562 cells stably expressing either dCas9-VP64-BFP or dCas9-SunTag10x_v4
together with scFv-GCN4-GFP-VP64 were infected with lentivirus encoding
individual sgRNAs (sequences provided in the Extended Experimental Proce-
dures) targeting the CXCR4 and CDKN1B promoters, as well as BFP and a pu-
romycin resistance gene. Cells were then selectedwith 0.7–1 mg/ml puromycin
for 3 days. Measurements of CXCR4 protein levels were performed by FACS
as described previously (Gilbert et al., 2013). For themeasurement of CDKN1B
mRNA levels, total RNA was isolated with Trizol (Ambion), and cDNA was syn-
thesized using the SuperScript cDNA synthesis kit VILO (Life Technologies).
qPCR primers are listed in the Extended Experimental Procedures.
Transwell Migration
Recombinant human SDF1a (Peprotech) was used as a chemoattractant for
the migration assay. K562 cells were cultured in RPMI-1640 with 2% FCSfor 16 hr. 75,000 cells were counted and resuspended in RPMI-1640/2%
FCS and added to the upper chamber of 24-well Transwell inserts (8-micron
pore size polyethylene terephthalate, Millipore), and 200 ng/ml SDF1a was
added to the lower chamber. The number of K562 cells that migrated to the
lower chamber was quantified after 5 hr by flow cytometry on a BD Bioscience
LSR-II flow cytometer.
K562 Growth Rate Measurements
K562 cells stably expressing either dCas9-VP64-BFP alone or dCas9-
SunTag10x_v4 together with scFv-GCN4-GFP-VP64 were infected with lenti-
virus encoding indicated sgRNAs together with BFP at an MOI of 0.3. Two
days after infection, the fraction of BFP-positive cells was determined by
FACS. Cells were grown for 2 weeks, after which the fraction of BFP positive
cells was remeasured. In cells infected with a control sgRNA, the fraction of
BFP-positive cells remained constant over time. In parallel, the cell doubling
time of uninfected cells was determined. Using the cell doubling time and
the fraction of BFP-positive cells at day 3 and day 14, the growth rate of
BFP positive cells was determined compared to uninfected control cells to
determine the growth rate of sgRNA-expressing cells.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Extended Experimental Procedures, five
figures, one table, and seven movies and can be found with this article online
at http://dx.doi.org/10.1016/j.cell.2014.09.039.
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